NCT00865163CompletedNot Applicable
LASER: Real Life Antithrombotic Stent Evaluation Registry
Stiftung Institut fuer Herzinfarktforschung2 sites in 1 country915 target enrollmentStarted: November 2008Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 915
- Locations
- 2
Study Overview
Brief Summary
LASER is designed to gather data about ischemic an bleeding complications for a period of 12 months after a PCI with the aim to optimize the therapy of these patients.
Detailed Description
The LASER Registry will collect data from unselected patients on how the problem of stents on the background of full anticoagulation is approached by the investigators. On the collected data the LASER registry will
- document the frequently used treatment modalities how patients requiring stents on the background of full anticoagulation with Vitamin K Antagonists are currently managed
- will document the associated cardiac event rates with each currently used treatment strategy
- will document the associated bleeding rates with each currently used treatment strategy
With these data available, the LASER Registry will allow
- to define an optimised treatment regimen for the treatment of patients on full anticoagulation with Vitamin K Antagonists receiving one or more coronary stents
- to allow the appropriate sample size calculation for the design of a subsequent randomised comparison of continuous triple anticoagulation versus this optimised treatment regimen in such patients.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients with significant symptomatic coronary artery disease (stable angina class II or more (CCS) , unstable angina, NSTEMI, or STEMI) and who for this reason do undergo percutaneous coronary revascularization with one or more drug eluting stent(s) (DES) or bare metal stent(s)
- •Patients requiring Vitamin K Antagonists based full anticoagulation therapy (target INR 2-4,5) for any clinical indication
- •Age: >18 years; no upper age limit
- •Informed consent has been obtained that the patient agrees to be fol-lowed up for up to one year
Exclusion Criteria
- •Patients who have been treated with a combined anticoagulant & antiplatelet therapy within the previous two months
- •Overt or constant occult bleeding that cannot adequately be treated (proton pump inhibitors, H2-blockers e.g.)
- •Any contraindication to the use of thienopyridines
- •Any contraindication to the use of aspirin
- •Severe liver or kidney disease
- •Any reason that creates sufficient doubts that follow-up can be obtained with reasonable efforts
- •Any other reason that in the eye of the investigator makes the patient unsuitable for the participation in the registry
- •For female patients only: pregnant or not on oral contraceptives or child bearing potential
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Recruiting
Not Applicable
REGistry of Long-term AnTithrombotic TherApy-2Atrial FibrillationNCT04347187National Medical Research Center for Cardiology, Ministry of Health of Russian Federation2,000
Recruiting
Not Applicable
REGistry of Long-term AnTithrombotic TherApy-1Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))Peripheral Artery DiseaseNCT04347200National Medical Research Center for Cardiology, Ministry of Health of Russian Federation2,000
Recruiting
Not Applicable
Laser In Situ Fenestration StudyEndovascular Aneurysm RepairAortic AneurysmNCT06411990Jonathan Bath15
Active, not recruiting
Not Applicable
Leiden Thrombosis Recurrence Risk PreventionVenous ThrombosesDeep Vein ThrombosisPulmonary EmbolismVenous ThromboembolismNCT06087952Leiden University Medical Center608
Completed
Not Applicable
Thromboelastography, Platelet Function and Platelet Recovery in Haemato-oncologic Patients With ThrombocytopeniaBone Marrow DiseasesLymphomaNCT01928017University of Bergen13